Gayle Deflin, Director at Amphastar Pharmaceuticals, Inc. (AMPH), sold 1,500 shares at $43.15 ($65K) on 2023-05-15, disclosed to the SEC on 2023-05-17.
Open-market sale of $65k AMPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |